[{"address1": "7800 Susquehanna St.", "address2": "Suite 505", "city": "Pittsburgh", "state": "PA", "zip": "15208", "country": "United States", "phone": "412 894 1853", "website": "https://lipella.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jonathan  Kaufman M.B.A., Ph.D.", "age": 57, "title": "Co-Founder, Chairman, CEO, President, Secretary & Treasurer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 233300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael B. Chancellor M.D.", "age": 66, "title": "Co-Founder, Chief Medical Officer & Director", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 225000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas  Johnston CPA", "age": 39, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 165000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michele  Gruber", "title": "Director of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Janet  Okonski", "title": "Director of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Katie  Johnston", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.59, "open": 0.6, "dayLow": 0.6, "dayHigh": 0.6, "regularMarketPreviousClose": 0.59, "regularMarketOpen": 0.6, "regularMarketDayLow": 0.6, "regularMarketDayHigh": 0.6, "payoutRatio": 0.0, "beta": -0.093, "forwardPE": -0.1875, "volume": 2029, "regularMarketVolume": 2029, "averageVolume": 22040, "averageVolume10days": 4890, "averageDailyVolume10Day": 4890, "bid": 0.6, "ask": 0.6406, "bidSize": 4547, "askSize": 2000, "marketCap": 2772504, "fiftyTwoWeekLow": 0.55, "fiftyTwoWeekHigh": 7.31, "priceToSalesTrailing12Months": 5.8968997, "fiftyDayAverage": 0.66618, "twoHundredDayAverage": 2.173665, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 452835, "profitMargins": 0.0, "floatShares": 4329355, "sharesOutstanding": 4620840, "sharesShort": 100093, "sharesShortPriorMonth": 133447, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.0224, "heldPercentInsiders": 0.06525, "heldPercentInstitutions": 0.0135, "shortRatio": 3.32, "shortPercentOfFloat": 0.0235, "impliedSharesOutstanding": 4620840, "bookValue": 0.614, "priceToBook": 0.9771987, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -5520318, "trailingEps": -3.33, "forwardEps": -3.2, "lastSplitFactor": "1:8", "lastSplitDate": 1731024000, "enterpriseToRevenue": 0.963, "enterpriseToEbitda": -0.081, "52WeekChange": -0.81279206, "SandP52WeekChange": 0.16885936, "quoteType": "EQUITY", "currentPrice": 0.6, "recommendationKey": "none", "totalCash": 2781828, "totalCashPerShare": 0.602, "ebitda": -5592217, "totalDebt": 274539, "quickRatio": 3.781, "currentRatio": 4.602, "totalRevenue": 470163, "debtToEquity": 10.014, "revenuePerShare": 0.216, "returnOnAssets": -1.18454, "returnOnEquity": -2.4835699, "grossProfits": -3423922, "freeCashflow": -2477698, "operatingCashflow": -4502780, "revenueGrowth": -0.364, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -15.641899, "financialCurrency": "USD", "symbol": "LIPO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "ipoExpectedDate": "2022-12-20", "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1757703812, "exchange": "NCM", "messageBoardId": "finmb_35907207", "exchangeTimezoneName": "America/New_York", "market": "us_market", "shortName": "Lipella Pharmaceuticals Inc.", "longName": "Lipella Pharmaceuticals Inc.", "epsTrailingTwelveMonths": -3.33, "epsForward": -3.2, "fiftyDayAverageChange": -0.06617999, "fiftyDayAverageChangePercent": -0.0993425, "twoHundredDayAverageChange": -1.573665, "twoHundredDayAverageChangePercent": -0.7239685, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "regularMarketChangePercent": 1.6949238, "regularMarketPrice": 0.6, "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "esgPopulated": false, "regularMarketChange": 0.01000005, "regularMarketDayRange": "0.6 - 0.6", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 22040, "fiftyTwoWeekLowChange": 0.050000012, "fiftyTwoWeekLowChangePercent": 0.09090911, "fiftyTwoWeekRange": "0.55 - 7.31", "fiftyTwoWeekHighChange": -6.71, "fiftyTwoWeekHighChangePercent": -0.91792065, "fiftyTwoWeekChangePercent": -81.279205, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1671460200000, "displayName": "Lipella Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-09-13"}]